Watchlist Price Alert

(XBI)

AMEX: XBI · Real-Time Price · USD

79.01

1.43 (1.84%)

At close: May 16, 2025, 3:59 PM

77.91

-1.39%

Pre-market: May 19, 2025, 04:41 AM EDT

1.84% (1D)

Bid	77.5
Market Cap	5.27B
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	n/a
PE Ratio (ttm)	n/a
Forward PE	n/a
Analyst	n/a

Ask	78.81
Volume	8,323,987
Avg. Volume (20D)	11,750,045
Open	77.87
Previous Close	77.58
Day's Range	77.33 - 79.16
52-Week Range	66.66 - 105.47
Beta	undefined

About XBI

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol XBI

Website n/a

Full Company Profile

Why Price Moved

1 week ago

-6.63%

Shares of vaccine and gene therapy stocks are trad... Unlock content with Pro Subscription

News

6 days ago · marketwatch.com

Trump is right about drug prices. He's just going about it all wrong.

The stock market doesn't believe the president about prescription drugs.

1 week ago · seekingalpha.com

Trump Declares War On Pharma Drug Pricing, But The Stocks Aren't Tanking - Yet

President Trump has announced today he plans to reduce U.S. drug prices by 30-80% via an Executive Order, targeting Big Pharma's high costs and profits. U.S. drug prices are significantly higher (up t...

6 days ago · zacks.com

Surprise Breakthrough: US-China Talks Spark Market Rally

An unexpected thaw in US-China trade relations is sending US equity markets soaring this morning.

1 week ago · zacks.com

Is SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now?

The SPDR S&P Biotech ETF (XBI) was launched on 01/31/2006, and is a smart beta exchange traded fund designed to offer broad exposure to the Health Care ETFs category of the market.

1 month ago · youtube.com

Sell into strength in pharma, says Mizuho's Jared Holz

Jared Holz, Mizuho, joins 'Fast Money' to talk a rebound in biotech stocks and what new tariffs mean for the pharmaceuticals space.

1 month ago · zacks.com

Should You Invest in the SPDR S&P Biotech ETF (XBI)?

Looking for broad exposure to the Healthcare - Biotech segment of the equity market? You should consider the SPDR S&P Biotech ETF (XBI), a passively managed exchange traded fund launched on 01/31/2006...

1 month ago · nypost.com

Drug stocks sink as FDA's top vaccine official is ousted in Trump overhaul

Shares of U.S. drugmakers fell on Monday after reports that the Food and Drug Administration's top vaccine official was forced to resign, the most high-profile exit at the regulator as the Trump admin...

2 months ago · youtube.com

Trade Tracker: Joe Terranova sells the XBI, buys Amgen

Joe Terranova, Senior Managing Director for Virtus Investment Partners, joins CNBC's "Halftime Report" to detail his latest portfolio moves.

2 months ago · seekingalpha.com

Invest In A New Biotech Bull Market With XBI And IBB

Biotech stocks are oversold. This near-term bottom might be the start of a long-term bull run. IBB and XBI offer different advantages. IBB can benefit from the flight to safety trade. XBI provides mor...